
Fellow Cardiología Intervenciónista // Crossfit Athlete // #SoMe Editor @smexcardiologia. Siempre busca la felicidad..... nunca dejes ir una oportunidad!!
Santiago de Compostela, España
Joined June 2010
- Tweets1.1K
- Following191
- Followers280
- Likes1.7K
Alfonso Mitre retweeted
👉Interventional cardiology FELLOWSHIP applications open for 2029-2031 in HCU Valladolid
👉interviews on 14th December 2027
👉if interested please send CV & Recommendation letters to [email protected]
@shci_sec @PCRonline @escardio @EAPCIPresident @Carlos_Cortes_V
Alfonso Mitre retweeted
¿El ejercicio intenso puede alterar los niveles de Lipoproteína-a de tal forma que un médico podría clasificar erróneamente el riesgo de un deportista? Aquí te lo explico .
fernandodelaguia.com/el-ejer… #CardiologiaDeportiva #SportsCardiology
Presented at #TCT2026:
In patients with moderate aortic stenosis and high-risk features, the percentage who died or had a heart-failure event within 2 years was lower with transcatheter aortic-valve replacement than with surveillance (16.7% vs. 23.9%). Full PROGRESS trial results: nej.md/4eUv9kA
@crfheart
Alfonso Mitre retweeted
❤️🩹 Dosis de inicio y objetivo: la tabla de la guía ESC 2026 · ESPACIO Insuficiencia cardiaca
¿Con cuánto se empieza y hasta dónde se sube? Abre el módulo y tendrás la dosis de inicio y la dosis objetivo de los 23 fármacos de la tabla 11 de la guía ESC 2026, con sus notas y cómo se titula.
👉 cardioteca.com/espacio-insuf…
📚 En el ESPACIO de insuficiencia cardiaca, 62 módulos: cardioteca.com/espacio-insuf…
#ESPACIOSCardioTeca #insuficienciacardiaca #cardiologia #MedicinaDeFamilia #MedicinaInterna #SEMI #SEMERGEN #semFYC
Alfonso Mitre retweeted
🫀 Clopidogrel o aspirina en monoterapia tras la ICP: ¿influye el sexo? En el SMART-CHOICE 3, el clopidogrel redujo muerte, infarto o ictus en mujeres (4,3% vs 9,4%), con la misma tendencia en hombres y sin interacción por sexo.
eurointervention.pcronline.c…
#Hemodinamica
Alfonso Mitre retweeted
Consenso ELAACC sobre imagen multimodalidad en el cierre de orejuela: eco 3D y TC para planificación, guía intraprocedimiento y seguimiento. Un marco unificado para estandarizar la práctica. Con @freixa_xavier e @icruzgonzalez entre los autores. 👇
#Hemodinamica #CierreOrejuela
This ELAACC expert consensus provides a unified multimodality imaging framework for preprocedural planning, intraprocedural guidance, and postprocedural follow-up, aiming to standardise workflows and support safe, reproducible LAAC practice.
Read now: eurointervention.pcronline.c…
#LAAC #CardiacImaging #StructuralHeart
@RaberLorenz @freixa_xavier @Nielsen_Kudsk @tomdepotter @rroku_andi @icruzgonzalez @DrGarot
Alfonso Mitre retweeted
International Day for Interventional Cardiology: the first coronary #angioplasty
On 16 September 1977, Andreas Grüntzig & his team made history, and changed the lives of millions of patients forever.
Standing on the shoulders of the giants that came before him, this transformative vision led to an entirely new field of medicine.
What began nearly five decades ago with coronary angioplasty has grown into the broad field of interventional cardiology, transforming cardiovascular care through research, innovation and technological progress.
As the field has evolved, so has the need to learn from experience, share knowledge and shape what comes next. Join us in 2027 at #EuroPCR to mark this landmark moment!
📅pcronline.com/Courses/EuroPC…
#medicalhistory #interventionalcardiologist #cathlab #cathlabteam
@NievesGonzalo1 @CuissetDr @nicolasdumonte1 @EmanueleBarba13
Alfonso Mitre retweeted
🫀 En @RevEspCardiol — REC Interventional Cardiology: TAVI y dispositivos cardiacos implantables, una combinación cada vez más frecuente. ¿Cómo programar el dispositivo para optimizar ambos? Una guía práctica del equipo de @ignamatsant .
recintervcardiol.org/es/arti…
#Hemodinamica
Alfonso Mitre retweeted
TEER en regurgitación mitral secundaria: no todos los pacientes se benefician igual. Selección, timing y fenotipo son clave para lograr beneficio clínico. Un State-of-the-Art que aclara el panorama. 👇
#Hemodinamica #IntervencionismoEstructural
How is TEER reshaping the management of secondary mitral regurgitation?
This State-of-the-Art reviews the evolving evidence for TEER in heart failure, highlighting the importance of patient selection, optimal timing, and MR phenotype in achieving clinical benefit.
🔗eurointervention.pcronline.c…
@Jmparadis27
Alfonso Mitre retweeted
🫀#ESCCongress wraps in Munich with practice-shaping trials. Cardiology keeps moving fast. #Cardiology #CardioTwitter #CardioEd @escardio @ESC_President @CMichaelGibson @JGrapsa @drjohnm @DrMarthaGulati @ErinMichos @mirvatalasnag @Drroxmehran @DFCapodanno @DLBHATTMD
Alfonso Mitre retweeted
MINOCA is a working diagnosis, not a destination. Redefining #MINOCA around myocardial injury, keeping the diagnosis open until the underlying mechanism is identified. Name the mechanism, then treat it. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#MINOCA #precisemedicine #cardiotwitter @ESC_Journals @escardio
Alfonso Mitre retweeted
The 10 trials I am most looking forward to at the ESC Hot Lines next week (in no particular order):
LIBREXIA-ACS, where milvexian could end up like apixaban in APPRAISE-2, perhaps with less bleeding. Rivaroxaban did not exactly have an easy story after ATLAS ACS 2 either, despite the positive results. Although we know the trial was stopped for futility, the data remain important in the rollercoaster of FXI inhibitor trials.
EPIDAURUS, because I will be the Discussant in Hot Line 3. It compares ticagrelor or prasugrel with clopidogrel in patients with atrial fibrillation and acute coronary syndrome. So I know everything about it, but I am not telling you.
SWITCH-SWEDEHEART, because if this trial is positive for prasugrel, this might finally be the moment when I call back all my patients on ticagrelor and switch them one by one. If not, we can say we have been joking all along and that ISAR-REACT 5 was just an episode.
PREMIUM, because after NEOMINDSET and STOPDAPT-3, a third negative trial for an aspirin-free strategy (meaning P2Y12 inhibitor monotherapy from the outset) would probably put this rather radical idea to rest, making it indefensible.
ISOLEDS, comparing OCT- versus IVUS-guided PCI in distal left main disease. After OPTIMAL and IVUS-CHIP, which we are still recovering from, we really need something that leaves angiography out of the comparison.
TAVI-PCI, because I don’t know about you, but after NOTION-3 and PRO-TAVI, I am still somewhat confused.
POPular-ACE, one of my favourites because it addresses a simple question with a potentially clear answer that we could implement in the cath lab the very next day: do we actually need protamine after TAVI or not?
AIR-STEMI, continuing the elemental saga of the Ferrara group (the same investigators behind FIRE) this time using angio-derived FFR to identify non-culprit lesions in STEMI. There is some confusion here too, given that FLOWER-MI was negative while FRAME-AMI was positive.
A-CLOSE, evaluating chronic clopidogrel monotherapy and continuing the story started by HOST-EXAM and SMART-CHOICE 3 against aspirin, while resembling OPT-BIRISK in its comparison with DAPT.
PRAGUE-26, which deserves a special mention because I really like the idea of tackling a complicated problem with an extremely simple and inexpensive approach. The results could surprise us and tell us that the solution has been sitting right there all along: alteplase directly instilled into the pulmonary arteries—a strategy we practically never use, and perhaps we are wrong not to.
Alfonso Mitre retweeted
Welcome to our AUGUST 12 issue of #JACCCaseReports @JACCJournals
jacc.org/journal/case-report….
Full PDF here:
jacc.org/doi/10.1016/S2666-0…
@minnowwalsh
@hmkyale
Coronary, Peripheral and Structural Interventions:
Percutaneous Retrieval Strategies Following Left Atrial Appendage Occluder and Peri-Device Leak Closure Embolization
jacc.org/doi/10.1016/j.jacca…
Retrograde Recanalization of Occluded Pulmonary Arteries via Percutaneous Transluminal Pulmonary Angioplasty
jacc.org/doi/10.1016/j.jacca…
Facilitating Tricuspid Edge-to-Edge Repair in Torrential Regurgitation Using Temporary Superior Vena Cava Balloon Occlusion
jacc.org/doi/10.1016/j.jacca…
Closing the Gap From Above: Vena Cava Occlusion for Coaptation-Gap Reduction During Tricuspid Edge-to-Edge Repair
jacc.org/doi/10.1016/j.jacca…
Arteriopathy of the Internal Mammary Artery: Implications for Patients With Spontaneous Coronary Artery Dissection
jacc.org/doi/10.1016/j.jacca…
Chronic Total Occlusion Recanalization in a 14-Year-Old Girl With Pseudoxanthoma Elasticum: IVUS-Guided Stentless Strategy
jacc.org/doi/10.1016/j.jacca…
Recurrent Coronary Restenosis in Takayasu Arteritis: A Stent-Sparing Strategy
jacc.org/doi/10.1016/j.jacca…
Percutaneous Closure of Left Ventricular Apex Perforation After Transcatheter Aortic Valve Replacement Valve-in-Valve
jacc.org/doi/10.1016/j.jacca…
Off-Label 16-mm VSD Occluder for Closure of a Giant PDA With Severe Pulmonary Hypertension
jacc.org/doi/10.1016/j.jacca…
Embolic MINOCA From Mechanical Aortic Valve Thrombosis: A Potential Role of Prosthesis–Patient Mismatch
jacc.org/doi/10.1016/j.jacca…
Progressive Enlargement of a Coronary Artery Communication With an Atrial Septal Defect Closure Device
jacc.org/doi/10.1016/j.jacca…
Neovascularization and Neo-Endothelialization After Atrial Septal Defect Closure
jacc.org/doi/10.1016/j.jacca…
Transcatheter Mitral Edge-to-Edge Repair With Intra-Aortic Balloon Pump Support in Severe Left Ventricular Dysfunction
jacc.org/doi/10.1016/j.jacca…
Congenital Heart Disease:
Feasibility of 35-mm Balloon-Expandable Transcatheter Pulmonary Valve Implantation in Extra-Large Native Right Ventricular Outflow Tracts
jacc.org/doi/10.1016/j.jacca…
Sotatercept in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome
jacc.org/doi/10.1016/j.jacca…
Eisenmenger Syndrome Enters the Sotatercept Era
jacc.org/doi/10.1016/j.jacca…
Eisenmenger Syndrome Hidden by Unrepaired Patent Ductus Arteriosus: Diagnosis After Delivery
jacc.org/doi/10.1016/j.jacca…
Eisenmenger Syndrome Complicated by Hemorrhagic Hereditary Telangiectasia: Unique Intersection of Hemorrhage, Cyanosis, and Thrombosis
jacc.org/doi/10.1016/j.jacca…
Catastrophic Pediatric Stroke Following Attempted Transcatheter Ventricular Septal Defect Closure
jacc.org/doi/10.1016/j.jacca…
When the Cure Injures: Lessons From a Catastrophic Stroke After Transcatheter VSD Closure
jacc.org/doi/10.1016/j.jacca…
ASD Occluder Used to Close a Mustard Baffle Leak
jacc.org/doi/10.1016/j.jacca…
Atrial Septal Defect Closure With Persistently Elevated Pulmonary Vascular Resistance
jacc.org/doi/10.1016/j.jacca…
Risk Refinement in the “Treat-to-Repair Era”
jacc.org/doi/10.1016/j.jacca…
Rhythm Disorders and Electrophysiology:
Progressive Giant Left Atrial Appendage Thrombus After Aborted Appendage Occlusion Despite Anticoagulation
jacc.org/doi/10.1016/j.jacca…
The Vulnerable Patient and the Vulnerable Appendage: Redefining Stroke Risk After Unsuccessful Left Atrial Appendage Occlusion
jacc.org/doi/10.1016/j.jacca…
Polymorphic Ventricular Tachycardia and Torsades in Methadone Therapy Captured by Loop Recorder
jacc.org/doi/10.1016/j.jacca…
Baseline Hypohaptoglobinemia as a Predisposing Factor for Hemolysis-Related Acute Kidney Injury After Pulsed-Field Ablation
jacc.org/doi/10.1016/j.jacca…
Leadless Pacemaker Dysfunction From Interference by a Retained Transvenous Pacemaker With Active Minute Ventilation Sensor
jacc.org/doi/10.1016/j.jacca…
Occult Idiopathic Ventricular Fibrillation After Preoperative Cardiovascular Evaluation
jacc.org/doi/10.1016/j.jacca…
Fundamental Anatomy and Its Impact on Clinical Practice: The Rightward Extension of Bachmann’s Bundle (Part II-III)
jacc.org/doi/10.1016/j.jacca…
Cardio-Oncology:
Osteosarcoma in a Young Patient: When the Tumor Reaches the Heart
jacc.org/doi/10.1016/j.jacca…
Acute Pericarditis After Targeted Kinase Inhibitor Therapy in Acute Leukemia
jacc.org/doi/10.1016/j.jacca…
Secondary Cardiac Lymphoma Presenting as Effusive–Constrictive Pericarditis
jacc.org/doi/10.1016/j.jacca…
Purulent Pericarditis After Esophageal Erosion With Streptococcus intermedius and Lactobacillus spp
jacc.org/doi/10.1016/j.jacca…
Avoiding Diagnostic Anchoring: The Case for Systematic Evaluation of Pericardial Disease
jacc.org/doi/10.1016/j.jacca…
Valvular Heart Disease:
Simultaneous Valve-in-Valve TAVR With Bioprosthetic Valve Fracture and Left Atrial Appendage Closure for Refractory Left Atrial Thrombus
jacc.org/doi/10.1016/j.jacca…
Coronary, Peripheral and Structural Interventions:
Pushing the Limits of Concomitant Structural Intervention: How Far Is Too Far?
jacc.org/doi/10.1016/j.jacca…
Valvular Heart Disease:
Bilateral Modified Self-Expanding Valve Implantation in Branch Pulmonary Arteries
jacc.org/doi/10.1016/j.jacca…
Chiari Network: An Innocent Bystander or the Culprit of Right-Sided Infective Endocarditis?
jacc.org/doi/10.1016/j.jacca…
@aroniskn
@CraigBasman
@JACabreraCardio
@MiChen__
@aabha_divya
@sarano_maurice
@MarcEngels7
@Miho_Fukui_
@CardioOncCO
@Nishaki1
@MMarinCuartas
@ChrissyMD2000f
@ACHDocTMoe
@PanjrathG
@jsaef1
@Kentso987
@m_taramasso
@SyedZaidMD
Alfonso Mitre retweeted
Can you remove a fully deployed coronary stent?
Yes. And in selected cases, you should.
New review in Catheterization and Cardiovascular Interventions: indications, technique, imaging, and a 7-step algorithm for percutaneous stentectomy.
doi.org/10.1002/ccd.70815
Alfonso Mitre retweeted
Revascularization of coronary artery disease in heart failure: a European Journal of Heart Failure expert consensus statement
#EJHF @ESC_Journals
academic.oup.com/eurjhf/adva…
@HanCardiomd @AmrAbdin10 @GiuseppeGalati_
Alfonso Mitre retweeted
🫀 ¿Sabes Hacer un VExUS Correctamente?
📍Dónde colocar el transductor
🌊Cómo obtener el Doppler
📈Cómo interpretar las ondas
⚠️Errores frecuentes
🔰📚The Ultrasound Journal
Artículo completo👇🏻🆓✅
t.me/SoMELaguna
Alfonso Mitre retweeted
JUST OUT and now FREE to download these 2 #JACCINT @JACCJournals SOTA #HeartValveCollaboratory Best Practices documents on Redo #TAVR!
Part 1: Short-in-Short, Short-in-Tall
jacc.org/doi/10.1016/j.jcin.…
Part 2: Tall-in-Short, Tall-in-Tall
jacc.org/doi/10.1016/j.jcin.…
Thank you to all the authors for their contributions!
@SyedZaidMD
@Bapat_SAVRTAVR
@Miho_Fukui_
@ignamatsant
@GuiAttizzaniMD
@Ravinay
@LPDasi
@HarryDauerman
@KashishGoelMD
@SachinGoelMD
@TsuyoshiKaneko1
@CathElectroSurg
@Khera_MD
@LandesUri
@David_Meier_
@modine_thomas
@OhnoTuri
@parma
@karlkpoon
@BaselRamlawiMD
@sellers_steph
@TagliariPaula
@G_Tarantini01
@didier_tchetche
@DrNVanMieghem
@JohnGraydonWebb
@PradeepYadavMD
@StevenYakubov
@TheDoctorMack
@MartyBLeon
Alfonso Mitre retweeted
Restoring coronary flow after STEMI is crucial, but successful reperfusion goes beyond reopening the epicardial artery.
Growing evidence suggests that limiting reperfusion-related microvascular damage, particularly intramyocardial hemorrhage (IMH), may help optimize the benefits of PCI and improve outcomes both early and over the longer term after MI.`
eurointervention.pcronline.c…
@AnkurKalraMD @rohandkumar1
Alfonso Mitre retweeted
🔍 Prueba de esfuerzo (ergometría): guía completa 2026 con las claves de la ESC 2024
Daniel del Hoyo @drdelhoyo
Descubre cuándo sigue teniendo valor la ergometría y cuándo debe dar paso a la imagen. Lee el artículo completo aquí: cardioteca.com/isquemia-angi…
📉 La sensibilidad y especificidad actuales de la ergometría son del 58% y 62% en cohortes contemporáneas, cifras inferiores a las que manejaban las guías de la SEC del año 2000
🗺️ Las guías ESC 2024 sitúan el TC coronario y las pruebas funcionales de imagen como primera línea, y reservan la ergometría para reclasificar la probabilidad baja (>5-15%) o para centros sin acceso a imagen
🏃 La capacidad funcional es el dato que más pesa: superar los 10 METs se asocia a un pronóstico excelente prácticamente con independencia del resultado del ST, y añadir imagen en ese grupo solo incrementa el coste
📊 El Duke Treadmill Score sigue siendo la herramienta pronóstica más validada: ≥+5 identifica riesgo bajo (~93% de supervivencia a 5 años) y ≤−11 riesgo alto (~67%)
Alfonso Mitre retweeted
🫀When transfemoral TAVI is not an option, what comes next?
In this article from The Essentials of #TAVI, Ulrich Schäfer reviews today's alternative access strategies and the key considerations for selecting the most appropriate approach.
Read the article:
pcronline.com/Cases-resource…
#StructuralHeart #InterventionalCardiology #HeartTeam #AorticStenosis #CardioEd #CardioEducation






































